| Similar Articles |
|---|
 |
The Motley Fool
March 26, 2007
Rich Duprey |
Breaking Chattem's Bond The consumer-products company should continue to give shareholders that soothing feeling.   |
The Motley Fool
July 11, 2007
Brian Orelli |
Icy Hot Results From Chattem The manufacturer of over-the-counter health-care products sees a huge increase in sales, but can it last? Investors, take note. |
The Motley Fool
September 27, 2007
Ryan Fuhrmann |
Chattem Chugs Along Shares of Chattem hit a new high today on solid results, and management ups its guidance, but what does that mean going forward? Investors should take note. |
The Motley Fool
October 11, 2006
Brian Lawler |
Monopoly Woes Help Chattem Grow Acquisitions boost the health-care brand owner's shares to new highs. |
The Motley Fool
February 13, 2007
Rich Duprey |
Chattem Has Relief on the Way The consumer products company has a portfolio of new products to drive revenues and profits. Investors, take note. |
The Motley Fool
September 26, 2007
Ryan Fuhrmann |
Foolish Forecast: Will Chattem's Recent Results Prove Soothing? In advance of earnings reports at the health-care and consumer-products firm, analysts are projecting 47% year-over-year growth due to recently acquired brands. |
The Motley Fool
April 17, 2006
Stephen D. Simpson |
Chattin' Up Chattem Great brands owned by a boring and unknown company. Might there be value afoot for investors? |
The Motley Fool
June 20, 2005
Matt Thurmond |
Chattem's High-Dollar Brands Health-care product maker generates big bucks from the body's annoying little problems. |
The Motley Fool
July 10, 2006
Stephen D. Simpson |
Chattem Holds Its Ground Management seems to have more faith in this consumer-goods company's business than Wall Street does. It is likely not a stock for the faint of heart. |
The Motley Fool
September 20, 2005
Jeremy MacNealy |
Chattem's Icy Hot Stock The stock of this manufacturer of over-the-counter health-care products is on an exceptional run. Shareholders may be wondering whether this is a good time to take some money off the table. |
The Motley Fool
March 19, 2007
Rich Duprey |
Foolish Forecast: Chatting Up Chattem The consumer products company will report first-quarter 2007 financial results shortly. Investors, here is what you can expect to see. |
The Motley Fool
October 7, 2010
Anand Chokkavelu |
How Johnson & Johnson Really Makes Money Hint: It's not Tylenol. |
The Motley Fool
February 26, 2004
W.D. Crotty |
Victoria's Not So Secret As expected, fourth-quarter results released this morning were strong. Same-store sales were up a robust 8%, revenue increased 9%, and net income rose 10% over the prior-year period. |
The Motley Fool
September 24, 2010
Anand Chokkavelu |
10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list |
The Motley Fool
December 22, 2009
Brian Orelli |
This Acquisition Is Icy Hot Expensive price, but Chattem may still be a good buy for sanofi-aventis. |
The Motley Fool
September 17, 2004
David Meier |
Gettin' Funky With Chattem Is Chattem good enough for your portfolio? |
The Motley Fool
July 17, 2006
Stephen D. Simpson |
Spectrum Finds New Lows For investors who've stuck with this troubled maker of batteries, shavers, and fish food, today's 29% drop in the stock is just another kick to the gut. |
The Motley Fool
May 10, 2006
Stephen D. Simpson |
A Broad Spectrum of Disappointment Will management at this company formerly known as Rayovac find a way to meet expectations? Investors, take note. |
The Motley Fool
May 17, 2006
Stephen D. Simpson |
Better Days in Sight for Church & Dwight The transition from acquirer to operator isn't easy, but the company seems to be managing. The market seems to know that, as these shares aren't priced for value investors, even if you give them some pretty healthy benefits of the doubt. |
BusinessWeek
September 20, 2004
Cooper & Madigan |
U.S.: The National Piggy Bank is Going Hungry A low savings rate threatens boomers' retirement -- and long-term growth. And part of the blame goes to the federal government's siphoning off a big chunk of domestic savings to fund enormous budget deficits. |
The Motley Fool
July 10, 2006
Stephen D. Simpson |
Same Old Look at Helen of Troy Another quarter goes by without clear signs of progress. Investors, take note. |
The Motley Fool
November 6, 2007
Saibal Saha |
The Power of Global Brands Corporate brands provide tremendous marketing leverage, however, a company that has a lot riding on its brand runs the risk that one unfavorable issue will affect the entire business. There are pros and cons to this strategy. |
The Motley Fool
October 5, 2009
Rick Aristotle Munarriz |
6 Reasons Not to Worry This Week Here are seven companies that analysts think will post healthier bottom lines this week: Chattem... Family Dollar...Helen of Troy... Monsanto... Ruby Tuesday... Tortoise Capital... |
The Motley Fool
March 1, 2007
Ryan Fuhrmann |
Growth and Income From Limited Brands As it stands, Limited Brands has a number of brands with solid growth potential but is also able to generate substantial cash flow and benefit shareholders via dividend payments and stock buybacks. |
The Motley Fool
November 9, 2005
Nathan Parmelee |
Destination: Limited Brands The company is counting on a number of new brands to drive future growth. There is a very good business here, with a history of delivering value to shareholders through capital gains and dividends. |
The Motley Fool
May 9, 2006
Stephen D. Simpson |
Uneven Progress at Helen of Troy Unfortunately, this beauty's still got some warts. However, a bargain is still a bargain. Investors, tread carefully, though, and keep an eye out for this year's proxy statement. |
The Motley Fool
January 12, 2012
Isaac Pino |
How American Brands Rule the World The best global brands can provide a boost to your portfolio. |
